2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction

FM Kusumoto, MH Schoenfeld, BL Wilkoff… - Heart …, 2017 - heartrhythmjournal.com
From the 1Mayo Clinic, Jacksonville, Florida, 2Yale University School of Medicine, New
Haven, Connecticut, 3Cleveland Clinic Lerner College of Medicine of Case Western …

[PDF][PDF] CONSENSUS DOCUMENT

C Blomstrom-Lundqvist, V Traykov, PA Erba… - European Heart …, 2020 - rythmolyon.fr
Pacemakers, implantable cardiac defibrillators (ICDs), and cardiac resynchronization
therapy (CRT) devices are lifesaving treatments for a number of cardiac conditions. Device …

European Heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections …

C Blomström-Lundqvist, V Traykov… - European Journal of …, 2020 - academic.oup.com
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …

EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators …

H Burri, C Starck, A Auricchio, M Biffi, M Burri… - EP …, 2021 - academic.oup.com
A thrombin-like serine protease, jararassin-I, was isolated from the venom of Bothrops
jararaca. The protein was obtained in high yield and purity by a single chromatographic step …

JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias

K Ono, Y Iwasaki, M Akao, T Ikeda, K Ishii… - Circulation …, 2022 - jstage.jst.go.jp
The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus …

DA Gorog, YX Gue, TF Chao, L Fauchier… - Thrombosis and …, 2022 - thieme-connect.com
While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE …

DH Birnie, JS Healey, GA Wells… - European heart …, 2018 - academic.oup.com
Aims Guidelines recommend warfarin continuation rather than heparin bridging for
pacemaker and defibrillator surgery, after the BRUISE CONTROL trial demonstrated an 80 …

Permanent leadless cardiac pacemaker therapy: a comprehensive review

FVY Tjong, VY Reddy - Circulation, 2017 - Am Heart Assoc
A new technology, leadless pacemaker therapy, was recently introduced clinically to
address lead-and pocket-related complications in conventional transvenous pacemaker …

Risk factors for infections involving cardiac implanted electronic devices

DH Birnie, J Wang, M Alings, F Philippon… - Journal of the American …, 2019 - jacc.org
Background: Cardiac implantable electronic device infection is a major complication that
usually requires device removal. PADIT (Prevention of Arrhythmia Device Infection Trial) …